| Yoga Group (n = 27) | Control Group (n = 21) | Total (n = 48) |  |
---|---|---|---|---|
 | N (%) | N (%) | N (%) | p |
Age, years (M ± SD) | 58.3 ± 9.3 | 55.0 ± 11.4 | 56.9 ± 10.3 | 0.28 |
Body Mass Index (M ± SD) | 26.6 ± 5.4 | 26.2 ± 5.6 | 26.5 ± 5.4 | 0.81 |
Gender | Â | Â | Â | 0.71 |
 Male | 2 (7.4) | 1 (4.8) | 3 (6.3) |  |
 Female | 25 (92.6) | 20 (95.2) | 45 (93.8) |  |
Race | Â | Â | Â | 0.42 |
 Caucasian | 25 (92.6) | 20 (95.2) | 45 (93.8) |  |
 Other | 2 (7.4) | 1 (4.8) | 3 (6.3) |  |
Diagnosis | Â | Â | Â | 0.53 |
 Polycythemia Vera | 10 (37.0) | 5 (23.8) | 15 (31.3) |  |
 Essential Thrombocythemia | 9 (33.3) | 10 (47.6) | 19 (39.6) |  |
 Myelofibrosis | 8 (29.6) | 6 (28.6) | 14 (29.2) |  |
Time Since Diagnosis | Â | Â | Â | 0.44 |
  < 1 year ago | 3 (11.1) | 4 (19.0) | 7 (14.6) |  |
 1–3 years ago | 4 (14.8) | 4 (19.0) | 8 (16.7) |  |
  > 3 years ago | 20 (74.1) | 13 (61.9) | 33 (68.8) |  |
Presence of Enlarged Spleen | Â | Â | Â | 0.45 |
 Yes | 8 (29.6) | 9 (42.9) | 17 (35.4) |  |
 No | 17 (63.0) | 12 (57.1) | 29 (60.4) |  |
 Missing | 2 (7.4) | 0 (0.0) | 2 (4.2) |  |
History of Anemia | Â | Â | Â | 0.23 |
 Yes | 15 (55.6) | 8 (38.1) | 23 (47.9) |  |
 No | 12 (44.4) | 13 (61.9) | 25 (52.1) |  |
Ruxolitinib/Other Janus Kinase-Inhibitor Treatment | Â | Â | 0.65 | |
 Yes | 5 (18.5) | 5 (23.8) | 10 (20.8) |  |
 No | 22 (81.5) | 16 (76.2) | 38 (79.2) |  |
Education | Â | Â | Â | 0.3 |
  < High School | 0 (0.0) | 0 (0.0) | 0 (0.0) |  |
 High school diploma | 2 (7.4) | 0 (0.0) | 2 (4.2) |  |
 Some college | 1 (3.7) | 2 (9.5) | 3 (6.3) |  |
 Associates/2-year degree | 3 (11.1) | 0 (0.0 | 3 (6.3) |  |
 Bachelors degree | 10 (37.0) | 8 (38.1) | 18 (37.5) |  |
 Graduate school or above | 11 (40.7) | 11 (52.4) | 22 (45.8) |  |
Marital status | Â | Â | Â | 0.28 |
 Single | 2 (7.4) | 0 (0.0) | 2 (4.2) |  |
 Partnered/in a relationship | 1 (3.7) | 2 (9.5) | 3 (6.3) |  |
 Married | 22 (81.5) | 19 (90.5) | 41 (85.4) |  |
 Separated | 2 (7.4) | 0 (0.0) | 2 (4.2) |  |
 Divorced | 0 (0.0) | 0 (0.0) | 0 (0.0) |  |